Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis

Clinical trials and observational studies have established cyclophosphamide (CY) or rituximab plus glucocorticoid (GC) as standard remission induction therapies in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). However, because these regimens are associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Harigai, Masayoshi, Tsutsumino, Michi, Takada, Hideto, Nagasaka, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506735/
https://www.ncbi.nlm.nih.gov/pubmed/30613065
http://dx.doi.org/10.3904/kjim.2018.366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506735/
https://www.ncbi.nlm.nih.gov/pubmed/30613065
http://dx.doi.org/10.3904/kjim.2018.366

Ejemplares similares